Large language models in oncology: a review

Large language models (LLMs) have demonstrated emergent human-like capabilities in natural language processing, leading to enthusiasm about their integration in healthcare environments. In oncology, where synthesising complex, multimodal data is essential, LLMs offer a promising avenue for supportin...

Full description

Saved in:
Bibliographic Details
Main Authors: Fei-Fei Liu, David Chen, Srinivas Raman, Rod Parsa, Karl Swanson, John-Jose Nunez, Andrew Critch, Danielle S Bitterman
Format: Article
Language:English
Published: BMJ Publishing Group 2025-05-01
Series:BMJ Oncology
Online Access:https://bmjoncology.bmj.com/content/4/1/e000759.full
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Large language models (LLMs) have demonstrated emergent human-like capabilities in natural language processing, leading to enthusiasm about their integration in healthcare environments. In oncology, where synthesising complex, multimodal data is essential, LLMs offer a promising avenue for supporting clinical decision-making, enhancing patient care, and accelerating research. This narrative review aims to highlight the current state of LLMs in medicine; applications of LLMs in oncology for clinicians, patients, and translational research; and future research directions. Clinician-facing LLMs enable clinical decision support and enable automated data extraction from electronic health records and literature to inform decision-making. Patient-facing LLMs offer the potential for disseminating accessible cancer information and psychosocial support. However, LLMs face limitations that must be addressed before clinical adoption, including risks of hallucinations, poor generalisation, ethical concerns, and scope integration. We propose the incorporation of LLMs within compound artificial intelligence systems to facilitate adoption and efficiency in oncology. This narrative review serves as a non-technical primer for clinicians to understand, evaluate, and participate as active users who can inform the design and iterative improvement of LLM technologies deployed in oncology settings. While LLMs are not intended to replace oncologists, they can serve as powerful tools to augment clinical expertise and patient-centred care, reinforcing their role as a valuable adjunct in the evolving landscape of oncology.
ISSN:2752-7948